RE:The bearsTucker320...Could not find any links that compare SZLS & Exas:us.
A little web rechearch indicate that...
EXAS:US Cologuard (Poop test) has a sencitivity of 92%(very good).
SZLS ColonSentry has a sencitivity of 94% ( even better).
EXAS:US Cologuard is approximately $600... to poop in a box.
SZLS Colonsentry is approximately $300... to give a sample of blood.
In the link below, no 3:
Potential for liquid biopsy(Blood tests)...seem to indicate that EXAS:US is behind SZLS in the blood test for early detection of cancer.
https://www.fool.com/investing/2018/01/10/3-slides-that-paint-a-great-picture-for-exact-scie.aspx In the link below:
-
Under Treats: it does say '' There is a not-so-insignifiant risk that another company could beat EXAS:US in developping liquid biopsy(blood tests) for early cancer detection.
https://www.fool.com/investing/2017/12/07/is-exact-sciences-corporation-exas-a-buy.aspx The big question is what are the chance that a more reliable blood test(94%) from SZLS, will be able to surpass EXAS:US poop in a box test(92%).
Tucker320 wrote: Interesting comments on the Anonymous post. There was a similar post on CEO.CA a few days ago by a long time holder.
All posts on public on forums, not including links to facts, should be taken for what they are, one persons opinion, motive unknown. I have seen such posts turn into reality over the years, so I never outright dismiss.
Nothing wrong with a company self promoting to wealthy investors, but we just closed a PP, not the news current investors, some at much higher levels, were waiting for. Due to statements made at the AGM and direction of SP, some form of business update is overdue.
How about looking out for CURRENT shareholders JHT?
Anyone have a link, or links, that accurately compare the SZLS and EXAS tests, in human testing.
A question that would have been mostly answered by a large health care deal signing.
We’re approximately half the cost, if accuracy is similar, that fact alone is huge, this should be flying..